Institutional

SpinalCyte, LLC Receives Institutional Review Board Approval for Phase I Clinical Trial

December 13, 2016 HOUSTON–(BUSINESS WIRE)–SpinalCyte, LLC, a Texas-based tissue engineering technology company focused on regrowth of the spinal disc nucleus…